Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04717375
Title	Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors
Recruitment	Active, not recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	Sanofi
Indications	renal cell carcinoma bladder urothelial carcinoma esophagus squamous cell carcinoma lung non-small cell carcinoma gastric adenocarcinoma cervical cancer Advanced Solid Tumor colorectal cancer transitional cell carcinoma skin squamous cell carcinoma hepatocellular carcinoma breast cancer esophagus adenocarcinoma cholangiocarcinoma gastroesophageal junction adenocarcinoma head and neck squamous cell carcinoma gallbladder cancer
Therapies	BND-22
Age Groups:	adult \| senior
Covered Countries	USA \| ISR \| GBR \| CAN